Latest Commercial Sales News

Memphasys has secured CE Mark approval for its Felix™ sperm selection system, enabling full commercial rollout across Europe and activating multi-year contracts worth over A$1.3 million. This milestone signals the company’s transition into a revenue-scaling phase with global growth ambitions.

Blue Star Helium has successfully started helium production at its Pinon Canyon plant, marking a key milestone as it prepares for commercial sales and expansion in 2026.

Sparc Technologies has achieved a significant commercial milestone with its first sale of ecosparc®, a graphene-based additive for protective coatings, to an Asian coatings company following successful proof-of-concept testing.

Rhythm Biosciences has begun commercialising ColoSTAT®, its blood-based colorectal cancer diagnostic test, following an updated ISO15189, 2022 accreditation. The test offers a new option for symptomatic patients where stool-based screening is unsuitable.

Orthocell has achieved its first commercial sales of Remplir™ in Hong Kong, marking a pivotal step in its Asian growth strategy and expanding its footprint across key global markets.

Lotus Resources reports promising progress at its Kayelekera uranium mine, targeting steady state production by Q1 2026 despite recent sulphuric acid supply constraints. The company is addressing supply issues with new sourcing and an on-schedule acid plant rebuild.

RareX Limited has signed a historic Mining Heritage Protection Agreement with the Jaru people, clearing a major hurdle for the Cummins Range rare earths project and paving the way for a Mining Lease.

State Gas Limited has independently certified a maiden 2P gas reserve of 30.2 petajoules at its Rolleston West Project, establishing a solid foundation for a pipeline-connected gas development aimed at the east coast market.

PainChek Ltd has achieved a pivotal FDA De Novo clearance for its AI-driven Adult pain assessment app, unlocking the US market and driving its annual recurring revenue to $5.6 million. The company also launched its Infant app, targeting a vast global market of pre-verbal children.

Zoono Group Limited reports strong progress in its shelf-life extension technology with 50 active trials worldwide and anticipates its first significant sales this quarter, supported by fresh funding and expanding market interest.

Terragen Holdings expands its probiotic product range into beef and lamb feedlots, secures key international approvals, and progresses large-scale trials while maintaining a $3 million cash reserve.

Australian Strategic Materials (ASM) reports significant progress in rare earth metals production and strategic growth, including a major capital raise and advances in its Dubbo and US projects.